Drupal.behaviors.print = function(context) {window.print();window.close();}>
Isis to Receive $1.1M from Alnylam
October 25, 2012
Isis to Receive $1.1M from Alnylam
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Oligo Drugs Advance in the Clinic in 2012 as Delivery Hurdles are Addressed
January 3, 2013 / Gene Silencing News
UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News
Alnylam Loses Cubist as RSV Partner, Stays Focused on ATTR Programs
February 14, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Novartis, Isis, and More
January 3, 2013 / Gene Silencing News
Alnylam Forms Alliance with Genzyme in ATTR, Adds Another Notch to Partnership Belt
October 25, 2012 / Gene Silencing News